Actively Recruiting
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Led by University of Colorado, Denver · Updated on 2025-10-15
152
Participants Needed
1
Research Sites
266 weeks
Total Duration
On this page
Sponsors
U
University of Colorado, Denver
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The over-arching aim of this study is to evaluate the effects of two specific anti-cancer chemotherapies, vincristine and doxorubicin, on bladder function and urine composition.
CONDITIONS
Official Title
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 5 to 13 years old
- History of cancer
- Treated with chemotherapy including vincristine and/or doxorubicin
- Completed chemotherapy at least one year before enrollment and survey completion
You will not qualify if you...
- Presence of a primary pelvic tumor
- History of pelvic irradiation
- Existing bladder or bowel dysfunction
- Spinal defects
- Neurologic disorders
- Neuro-oncologic tumor or brain metastasis
- Treatment with cyclophosphamide or ifosfamide
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045
Actively Recruiting
Research Team
G
Gemma Beltran
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here